Advertisement
News
Advertisement

Abbott gets EU approval of Crohn’s disease drug

Fri, 08/31/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

A drug approved to treat moderately-active Crohn’s disease, a chronic inflammatory bowel disease of the gastrointestinal tract, in the European Union has been approved to treat severely active patients with the disease.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading